Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)

Phase 4

Completed

Conditions: Low Back Pain
Spinal Stenosis

Interventions: Procedure: Epidural steroid with local anesthetic injection
Drug: Epidural local anesthetic injection
Drug: Epidural steroid injection

First Posted Date: 2010-11-10

Last Posted Date: 2017-12-13

Lead Sponsor: University of Washington

Target Recruit Count: 400

Registration Number: NCT01238536

Locations: 🇺🇸
Kaiser Permanente Northern California, Roseville, California, United States
🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 6 locations

Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer

Phase 1

Withdrawn

Conditions: HER2-positive Breast Cancer
Male Breast Cancer
Stage IV Breast Cancer

Interventions: Biological: HER-2/neu peptide vaccine
Drug: cyclophosphamide
Biological: ex vivo-expanded HER2-specific T cells
Other: laboratory biomarker analysis
Other: flow cytometry
Other: immunoenzyme technique

First Posted Date: 2010-10-13

Last Posted Date: 2013-05-17

Lead Sponsor: University of Washington

Registration Number: NCT01219907

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

MRI of the Liver With Eovist

Terminated

Conditions: Hepatocellular Carcinoma

First Posted Date: 2010-10-07

Last Posted Date: 2013-10-14

Lead Sponsor: University of Washington

Target Recruit Count: 4

Registration Number: NCT01215838

ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

Phase 1

Completed

Conditions: Healthy Males

Interventions: Drug: Acyline
Drug: Testosterone gel
Drug: Placebo ketoconazole
Drug: ketoconazole 400
Drug: Ketoconazole 800
Drug: Dutasteride
Drug: Anastrozole

First Posted Date: 2010-10-06

Last Posted Date: 2014-03-31

Lead Sponsor: University of Washington

Target Recruit Count: 46

Registration Number: NCT01215292

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Not Applicable

Completed

Conditions: Beta-Thalassemia

Interventions: Drug: Mozobil

First Posted Date: 2010-09-21

Last Posted Date: 2014-12-30

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT01206075

Locations: 🇬🇷
George Papanicolaou Hospital, Thessaloniki, Greece

Optimization of Human Cortical Stimulation

Conditions: Epilepsy
Brain Injury

Interventions: Procedure: Low-level cortical stimulation

First Posted Date: 2010-09-10

Last Posted Date: 2021-04-27

Lead Sponsor: University of Washington

Target Recruit Count: 8

Registration Number: NCT01198964

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial

Not Applicable

Completed

Conditions: Hiatal Hernia

Interventions: Device: Veritas® Collagen Matrix

First Posted Date: 2010-09-06

Last Posted Date: 2018-07-10

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT01195545

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Integrated Infectious Disease Capacity-Building Evaluation

Not Applicable

Completed

Conditions: Support for Midlevel Health Professionals
Diagnostic Training
Capacity Building

Interventions: Behavioral: Training and Supervision
Behavioral: Integrated Management of Infectious Disease (IMID)

First Posted Date: 2010-08-27

Last Posted Date: 2014-12-03

Lead Sponsor: University of Washington

Target Recruit Count: 72

Registration Number: NCT01190540

Locations: 🇺🇬
Infectious Disease Institute, Makerere University, Kampala, Uganda

Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)

Phase 2

Completed

Conditions: Chronic Posttraumatic Stress Disorder

Interventions: Drug: Psychotherapy plus Methylene Blue, USP
Behavioral: Psychotherapy plus Placebo
Behavioral: Delayed Psychotherapy

First Posted Date: 2010-08-25

Last Posted Date: 2017-06-14

Lead Sponsor: University of Washington

Target Recruit Count: 42

Registration Number: NCT01188694

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Texas, Austin, Texas, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision

Not Applicable

Completed

Conditions: HIV Infections
Cellular Phone
Acquired Immunodeficiency Syndrome
Circumcision, Male
Patient Compliance

Interventions: Other: Text Message

First Posted Date: 2010-08-23

Last Posted Date: 2015-01-16

Lead Sponsor: University of Washington

Target Recruit Count: 1200

Registration Number: NCT01186575

Locations: 🇰🇪
Nyanza Reproductive Health Society, Kisumu, Nyanza, Kenya

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy